Role of CT perfusion in monitoring and prediction of response to therapy of head and neck squamous cell carcinoma.
Lorenzo PredaSonia Francesca CalloniMarco Elvio Manlio MoscatelliMaria Cossu RoccaMassimo BellomiPublished in: BioMed research international (2014)
This review aims to summarize the technique and clinical applications of CT perfusion (CTp) of head and neck cancer. The most common pathologic type (90%) of head and neck cancer is squamous cell carcinoma (HNSCC): its diagnostic workup relies on CT and MRI, as they provide an accurate staging for the disease by determining tumour volume, assessing its extension, and detecting of lymph node metastases. Compared with conventional CT and MRI, CTp allows for obtaining measures of tumour vascular physiology and functional behaviour, and it has been demonstrated to be a feasible and useful tool in predicting local outcomes in patients undergoing radiation therapy and chemotherapy and may help monitor both treatments.
Keyphrases
- contrast enhanced
- magnetic resonance imaging
- lymph node
- computed tomography
- magnetic resonance
- dual energy
- squamous cell carcinoma
- image quality
- radiation therapy
- diffusion weighted imaging
- locally advanced
- patients undergoing
- neoadjuvant chemotherapy
- positron emission tomography
- early stage
- metabolic syndrome
- mesenchymal stem cells
- mass spectrometry
- sentinel lymph node